<https://www.mmitnetwork.com/#/schema/logo/image/>
<http://schema.org/inLanguage>
<https://www.mmitnetwork.com/aishealth/spotlight-on-market-access/fda-approval-gives-third-option-to-treat-rare-deadly-disease-2/>